Contract Service Directory

Mikart





Company Headquarters

1750 Chattahoochee Ave
Atlanta, GA 30318
United States

Company Description

Mikart’s 45+ years of experience in oral solid and nonsterile oral liquid dosage forms and specialization in pediatric, geriatric, and controlled-substance make us the ideal contract development and manufacturing organization partner — from formulation development through commercialization.

Contract Service Directory

    Related Content


    • Breaking News | Drug Delivery | Drug Development | Industry News
      Recipharm Invests in Inhalation Development Services

      Recipharm Invests in Inhalation Development Services

      Installs SprayVIEW system to support inhalation and nasal product development at RTP, NC facility
      12.09.19

    • Mikart

      Mikart's Gus Labella

      Mikart's associate director of formulation development talks about the company's services.
      Contract Pharma Staff


    • Analytical Services | Industry News | QA/QC
      Recipharm Launches Recipharm Analytical Solutions

      Recipharm Launches Recipharm Analytical Solutions

      Stand-alone service offers analytical services including method development, method validation, and stability program design and implementation
      11.04.19


    • Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
      BioInvent, Cancer Research UK Sign Manufacturing Pact

      BioInvent, Cancer Research UK Sign Manufacturing Pact

      Expected to generate approximately $3 million.
      10.23.19


    • Breaking News | Industry News
      VIDEO: Mikart

      VIDEO: Mikart's Gus Labella

      Mikart's associate director of formulation development talks about the company's services.
      10.11.19

    • Clinical Trials | Serialization | Supply Chain
      Anti-Counterfeiting in the Pharmaceutical Industry: An Evolution

      Anti-Counterfeiting in the Pharmaceutical Industry: An Evolution

      Keeping up with counterfeitors in the pharmaceutical industry is no easy task, but patients’ lives depend on it.
      Ben Locwin, Healthcare Science Advisors 10.04.19

    • APIs | Scale-up/Technology Transfer
      Drug Substances: Scale-Up Challenges

      Drug Substances: Scale-Up Challenges

      A look at the necessary steps and evaluations needed in order to manage complexities and reduce timelines.
      Anders Högdin, Senior Sales Director, Recipharm 09.16.19


    • Cytotoxics and High Potency Manufacturing
      API to ADC: A Journey Through High Potency

      API to ADC: A Journey Through High Potency

      This class of compounds represents a major advance in oncology research and treatment application.
      Maurits Janssen, Head Commercial Development API, Lonza Pharma & Biotech 09.16.19